Get started
Author

Hideki Kusagaya

Observed names: H Kusagaya, H. Kusagaya, Kusagaya, Hideki
OpenAlex ID: A5028983672
Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis
2010 · Kazuki Furuhashi, Takafumi Suda, et al. · Respiratory Medicine · 121
Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective Study
2020 · Yuzo Suzuki, Masato Karayama, et al. · Journal of Thoracic Oncology · 97
PDF
Idiopathic pleuroparenchymal fibroelastosis: consideration of a clinicopathological entity in a series of Japanese patients
2012 · Hideki Kusagaya, Yutaro Nakamura, et al. · BMC Pulmonary Medicine · 96
PDF
Toll-Like Receptor–Mediated Airway IL-17C Enhances Epithelial Host Defense in an Autocrine/Paracrine Manner
2013 · Hideki Kusagaya, Tomoyuki Fujisawa, et al. · American Journal of Respiratory Cell and Molecular Biology · 66
PDF
Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis‐associated ILD : A randomized, open‐label trial
2020 · Tomoyuki Fujisawa, Hironao Hozumi, et al. · Respirology · 57
Quantitative analysis of lung elastic fibers in idiopathic pleuroparenchymal fibroelastosis (IPPFE): comparison of clinical, radiological, and pathological findings with those of idiopathic pulmonary fibrosis (IPF)
2014 · Noriyuki Enomoto, Hideki Kusagaya, et al. · BMC Pulmonary Medicine · 49
PDF
Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer
2021 · Masato Karayama, Naoki Inui, et al. · Cancer Immunology Immunotherapy · 47
PDF
Evaluation of palonosetron and dexamethasone with or without aprepitant to prevent carboplatin-induced nausea and vomiting in patients with advanced non-small-cell lung cancer
2015 · Hideki Kusagaya, Naoki Inui, et al. · Lung Cancer · 41
Evaluation of Programmed Death Ligand 1 (PD-L1) Gene Amplification and Response to Nivolumab Monotherapy in Non–small Cell Lung Cancer
2020 · Yusuke Inoue, Katsuhiro Yoshimura, et al. · JAMA Network Open · 38
PDF
Olanzapine-containing antiemetic therapy for the prevention of carboplatin-induced nausea and vomiting
2019 · Kazuki Tanaka, Naoki Inui, et al. · Cancer Chemotherapy and Pharmacology · 36
Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD
2019 · Yuzo Suzuki, Naoki Inui, et al. · International Journal of COPD · 21
PDF
Clinical Outcomes of Anti-programmed Death-1 Antibody–Related Pneumonitis in Patients with Non-Small Cell Lung Cancer
2020 · Takafumi Koyauchi, Naoki Inui, et al. · SN Comprehensive Clinical Medicine · 18
IL-13 regulates IL-17C expression by suppressing NF-κB-mediated transcriptional activation in airway epithelial cells
2017 · Katsumasa Yamanaka, Tomoyuki Fujisawa, et al. · Biochemical and Biophysical Research Communications · 18
Synergistic Proinflammatory Responses by IL-17A and Toll-Like Receptor 3 in Human Airway Epithelial Cells
2015 · Kazutaka Mori, Tomoyuki Fujisawa, et al. · PLoS ONE · 14
PDF
Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysis
2021 · Koichi Miyashita, Masato Karayama, et al. · BMC Pulmonary Medicine · 8
PDF
Co-occurrence of Pneumoperitoneum and Pneumothorax in a Patient with Pleuroparenchymal Fibroelastosis
2015 · Hideki Kusagaya, Tomoyuki Fujisawa, et al. · American Journal of Respiratory and Critical Care Medicine · 8
Biweekly combination therapy with gemcitabine and carboplatin compared with gemcitabine monotherapy in elderly patients with advanced non-small-cell lung cancer: A randomized, phase-II study
2012 · Hideki Kusagaya, Naoki Inui, et al. · Lung Cancer · 8
Chemotherapy for patients with advanced lung cancer with interstitial lung disease: a prospective observational study
2022 · Keigo Koda, Yasunori Enomoto, et al. · Therapeutic Advances in Chronic Disease · 7
Evaluation of antibody levels over 3 years after 23-valent pneumococcal polysaccharide vaccination in patients with pulmonary diseases receiving steroids and immunosuppressive agents
2014 · Taisuke Akamatsu, Naoki Inui, et al. · Clinical Biochemistry · 7
Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutations
2020 · Yoichiro Aoshima, Masato Karayama, et al. · Investigational New Drugs · 6
PDF
A case of supernumerary intrathoracic rib
2017 · Masaki Ikeda, Ken-ichiro Inoue, et al. · Asian Cardiovascular and Thoracic Annals · 3
Efficacy of Combination Therapy with Prednisolone and Calcineurin Inhibitor in Patients with Myositis-Associated Interstitial Lung Disease
2020 · T. Fujisawa, H. Hozumi, et al. · American Journal of Respiratory and Critical Care Medicine · 2
Changes in cross-sectional area of pulmonary vessels on chest computed tomography after chemotherapy in patients with advanced non-squamous non-small-cell lung cancer
2016 · Masato Karayama, Naoki Inui, et al. · Cancer Chemotherapy and Pharmacology · 2
Systemic Air Embolism and Mediastinal Emphysema after Pneumonia
2021 · Sho Takuma, Hideki Kusagaya, et al. · American Journal of Respiratory and Critical Care Medicine · 1
A Case of Exacerbation of Postinfectious Organizing Pneumonia by Pembrolizumab
2019 · Sho Takuma, Hideki Kusagaya, et al. · Haigan · 1
PDF
Works count: 40
Citation count: 776
H-index: 14
I10-index: 14
Year
Topic
Type